South Dakota Gov. Kristi Noem addresses an abortion bill she will discusses in the upcoming state of the state address.
As the nation marks the 48th anniversary of Roe v. Wade and President Trump’s term has come to an end, questions remain about how the former administration had addressed congressional concerns surrounding Planned Parenthood Federation of America’s (PPFA) fetal-tissue practices and its lack of action that ultimately prompted criticism from conservatives.
Roughly a week before Trump left office, the Department of Health and Human Services (HHS) proposed a rule that would purportedly strengthen requirements for informed consent from mothers, as well as prevent fetal-tissue trafficking in federally funded studies issues raised after HHS terminated in 2018 its contract with a tissue procurer that worked with PPFA.
/PRNewswire/ The Sacramento Metropolitan Chamber of Commerce announced it will name Cate Dyer, CEO of StemExpress, the "Businesswoman of the Year" at their.
happy? what would make your lab happy? another 50 livers a week. in the video attracted by dyer s success, daleiden s tissue buyers actually wanted to partner up with stemexpress. realistically if we were to do an agreement with you guys dyer touts her close relationship with planned parenthood. i mean, planned parenthood is volume institutionition right. she discusses the qualms felt by some of the reseahers who receive the tissue her company provides such as when they send a fetal skull. tell the lab it s coming so they don t open the box. [ laughing ] it s almost like they don t want to know where it comes from. where they re like we need limbs, but no hands and feet need to be attached. in a video released september 1, daleiden talks with perrin larton from advanced bioresources. the whole point is to not have a live birth. so the doctors have all
one such company in this up and coming market is stemexpress. tucked into an office park in placerville, california, about an hour and a half east of sacramento. i feel like stemexpress does something very unique for medical research that most of these institutions, whether or not it s a small academic to a big pharmaceutical is not set up to produce those types of cells and specimens. 36-year-old ceo cate dyer who graduated with a sociology degree from sacramento state started stemexpress in 2010 with just $9,000. billing itself as the largest provider of maternal blood and fetal tissue globally it s grown by leaps and bounds, taking in $2.2 million in revenue in 2013. it s also gotten great press. inc. magazine listed stem express among the fastest growing women-led private
companies in america and dyer was featured in the article cracking the glass. she was listed as one of 14, quote, women who mean business in the sacramento business journal. any doubt that this is a business is expelled at the stemexpress website where the company s product lines and pricing are displayed. fetal tissue is only a portion of what they sell, but you can pick up items such as fetal liver stem progenitor cells for up to $24,000. that s right. $24,000 for this top-of-the-line product. stem express also markets cells for the development of humanized mice. there is still a lot of early experimentation work being done in the laboratory and work being done in animal models to see if you can take the tissue itself and try to make it differentiate into different kinds of tissue and different kinds of cells. there is also work being done to look at how the tissue would react to certain kinds of drugs. david daleiden targeted stemexpress early on in his investigation. on may